Unity Biotechnology Statistics

Total Valuation

LON:0YC0 has a market cap or net worth of GBP 1.41 million. The enterprise value is 5.64 million.

Market Cap	1.41M
Enterprise Value	5.64M

Important Dates

The next estimated earnings date is Tuesday, July 22, 2025.

Earnings Date	Jul 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	17.21M
Shares Outstanding	n/a
Shares Change (YoY)	+9.47%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	15.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-8.89
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.27
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.95

Current Ratio	1.95
Quick Ratio	1.87
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -231.27% and return on invested capital (ROIC) is -47.83%.

Return on Equity (ROE)	-231.27%
Return on Assets (ROA)	-38.89%
Return on Invested Capital (ROIC)	-47.83%
Return on Capital Employed (ROCE)	-130.44%
Revenue Per Employee	n/a
Profits Per Employee	-1.33M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-93.11%
50-Day Moving Average	0.71
200-Day Moving Average	1.31
Relative Strength Index (RSI)	20.80
Average Volume (20 Days)	54,215

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.73

Income Statement

Revenue	n/a
Gross Profit	-9.33M
Operating Income	-21.48M
Pretax Income	-21.29M
Net Income	-21.29M
EBITDA	-20.85M
EBIT	-21.48M
Earnings Per Share (EPS)	-1.26

Full Income Statement

Balance Sheet

The company has 13.11 million in cash and 17.50 million in debt, giving a net cash position of -4.39 million.

Cash & Cash Equivalents	13.11M
Total Debt	17.50M
Net Cash	-4.39M
Net Cash Per Share	n/a
Equity (Book Value)	-158,668
Book Value Per Share	-0.01
Working Capital	6.64M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-17.06M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0YC0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.47%
Shareholder Yield	n/a
Earnings Yield	-1,509.21%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1